Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Global Veterinary Dermatology Drugs Market (2021 to 2028) - Size, Share & Trends Analysis Report

      Research and Markets Logo

      News provided by

      Research and Markets

      Jan 18, 2022, 10:45 ET

      Share this article

      Share this article


      DUBLIN, Jan. 18, 2022 /PRNewswire/ -- The "Veterinary Dermatology Drugs Market Size, Share & Trends Analysis Report By Animal Type (Companion, Livestock), By Route Of Administration, By Indication, By Distribution Channel, By Region, and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.

      The global veterinary dermatology drugs market size is anticipated to reach USD 14.6 billion by 2028. The market is expected to expand at a CAGR of 9.3% from 2021 to 2028.

      Increasing incidences of dermatology diseases such as fleas and ticks and allergic dermatitis are expected to boost the market growth. Furthermore, a growing number of clinical trials related to veterinary dermatology drugs is also anticipated to fuel market growth.

      Due to the COVID-19 pandemic, some market players such as experience no negative impact. For instance, Elanco experienced a growth of 6.6% in its annual revenue. Also, Vetoquinol and Zoetis reported a growth of 8% and 6.6% in their annual revenue, respectively. On the other hand, Virbac reported a decline of 0.4% in its total revenue and a 6.9% decline in its companion animal parasiticides and dermatology segment as well as bovine parasiticides segment. This neutralized the impact of COVID-19 on the market.

      Growth in the companion animal population is expected to increase the demand for veterinary healthcare products, such as dermatology drugs, and boost the overall expenditure on pets. According to the American Pet Products Association report, overall spending in the U.S. pet industry was USD 95.7 Billion in 2019 and forecast to reach approximately USD 99 Billion in 2020. Veterinary care spending increased by 560% between 1994 and 2019.

      The market for veterinary dermatology drugs is fairly competitive. The most notable participants in the market are Zoetis, Virbac, and Elanco, along with other manufacturers. These players are involved in new product launches, acquisitions, and partnerships to gain a competitive edge over each other. For instance, in March 2021, Virbac obtained the rights to certain early-stage parasiticides products from Elanco, hence expanding its product portfolio. Also, in February 2021, Vetoquinol acquired the rights from Elanco for the Profender product family comprising of topical dewormer products, for the market in Canada. This expanded its geographical presence.

      Veterinary Dermatology Drugs Market Report Highlights

      • The companion animal segment held the dominant share of more than 70.0% in the animal type segment as of 2020 owing to the high pet ownership rate.
      • The oral segment held the largest market share of the route of administration segment as of 2020, accounting for more than 37.0% of the revenue share, owing to its easy availability.
      • The parasitic infections segment held the largest market share of the indication segment as of 2020, owing to a high prevalence of parasitic infections.
      • The hospital pharmacies segment held the largest market share of 42.4% in 2020 in the distribution channel segment.
      • In 2020, North America held the dominant share of the market owing to the increasing pet care expenditure.
      • In Asia Pacific, the market is expected to show lucrative growth over the forecast period owing to the growing demand for veterinary dermatology drugs in the region.

      Key Topics Covered:

      Chapter 1 Research Methodology & Scope

      Chapter 2 Executive Summary

      Chapter 3 Veterinary Dermatology Drugs Market Variables, Trends & Scope
      3.1 Market Lineage Outlook
      3.1.1 Parent Market Outlook
      3.1.2 Ancillary Market Outlook
      3.2 Penetration & Growth Prospect Mapping
      3.3 Veterinary Dermatology Drugs Market Dynamics
      3.3.1 Market Driver Analysis
      3.3.1.1 Increasing Pet Ownership
      3.3.1.2 Growing Number Of Clinical Trials Related To Veterinary Dermatology Drugs
      3.3.1.3 Rising Incidence Rate Of Parasitic As Well As Other Skin Diseases In Animals
      3.3.1.4 Investments By Market Players
      3.3.2 Market Restraint Analysis
      3.3.2.1 Lack Of Awareness In Developing Regions
      3.3.2.2 Disease Outbreaks
      3.3.3 Opportunities
      3.3.4 Challenges
      3.4 Veterinary Dermatology Drugs Market Analysis Tools: Porters
      3.4.1 Supplier Power: Low
      3.4.2 Buyer Power: Moderate To High
      3.4.3 Threat Of Substitutes: Low
      3.4.4 Threat Of New Entrants: Moderate
      3.4.5 Competitive Rivalry: High
      3.5 Veterinary Dermatology Drugs Market Analysis Tools: Pestel Analysis
      3.5.1 Political Landscape
      3.5.2 Economic Landscape
      3.5.3 Social Landscape
      3.5.4 Technology Landscape
      3.5.5 Legal Landscape
      3.6 Clinical Trial Analysis
      3.7 Consumer Preference Matrix
      3.8 Regulatory Landscape

      Chapter 4 Impact Of Covid-19 On Veterinary Dermatology Drugs Market
      4.1. Disease Prevalence Analysis
      4.2. Current And Future Impact Analysis
      4.3. Impact Of Covid-19 On Market Players

      Chapter 5 Veterinary Dermatology Drugs Market: Animal Type Estimates & Trend Analysis
      5.1 Veterinary Dermatology Drugs Market: Animal Type Movement Analysis
      5.2 Companion Animal
      5.2.1 Companion Animal Market Estimates And Forecasts, 2016 - 2028 (USD Million)
      5.3 Livestock Animal
      5.3.1 Livestock Animal Market Estimates And Forecasts, 2016 - 2028 (USD Million)

      Chapter 6 Veterinary Dermatology Drugs Market: Route Of Administration Estimates & Trend Analysis
      6.1 Veterinary Dermatology Drugs Market: Route Of Administration Movement Analysis
      6.2 Oral
      6.2.1 Oral Market Estimates And Forecasts, 2016 - 2028 (USD Million)
      6.3 Topical
      6.3.1 Topical Market Estimates And Forecasts, 2016 - 2028 (USD Million)
      6.4 InjecTable
      6.4.1 InjecTable Market Estimates And Forecasts, 2016 - 2028 (USD Million)

      Chapter 7 Veterinary Dermatology Drugs Market: Indication Estimates & Trend Analysis
      7.1 Veterinary Dermatology Drugs Market: Indication Movement Analysis
      7.2 Parasitic Infections
      7.2.1 Parasitic Infections Market Estimates And Forecasts, 2016 - 2028 (USD Million)
      7.3 Allergic Infections
      7.3.1 Allergic Infections Market Estimates And Forecasts, 2016 - 2028 (USD Million)
      7.4 Others
      7.4.1 Others Market Estimates And Forecasts, 2016 - 2028 (USD Million)

      Chapter 8 Veterinary Dermatology Drugs Market: Distribution Channel Estimates & Trend Analysis
      8.1 Veterinary Dermatology Drugs Market: Distribution Channel Movement Analysis
      8.2 Retail
      8.2.1 Retail Market Estimates And Forecasts, 2016 - 2028 (USD Million)
      8.3 E-Commerce
      8.3.1 E-Commerce Market Estimates And Forecasts, 2016 - 2028 (USD Million)
      8.4 Hospital Pharmacies
      8.4.1 Hospital Pharmacies Market Estimates And Forecasts, 2016 - 2028 (USD Million)

      Chapter 9 Veterinary Dermatology Drugs Market: Regional Estimates & Trend Analysis

      Chapter 10 Veterinary Dermatology Drugs Market Competitive & Vendor Landscape
      10.1 Participation Categorization
      10.2 Competitive Dashboard Analysis
      10.3 Public Companies
      10.3.1 Company Market Position Analysis
      10.3.2 Heat Map Analysis
      10.4 Private Companies
      10.4.1 Heat Map Analysis
      10.5 Detailed List Of Market Players

      Chapter 11 Company Profiles
      11.1 Elanco
      11.1.1 Company Overview
      11.1.2 Financial Performance
      11.1.3 Product Benchmarking
      11.1.4 Strategic Initiatives
      11.2 Vetoquinol S.A.
      11.2.1 Company Overview
      11.2.2 Financial Performance
      11.2.3 Product Benchmarking
      11.2.4 Strategic Initiatives
      11.3 Ceva
      11.3.1 Company Overview
      11.3.2 Financial Performance
      11.3.3 Product Benchmarking
      11.3.4 Strategic Initiatives
      11.4 Merck & Co., Inc.
      11.4.1 Company Overview
      11.4.2 Financial Performance
      11.4.3 Product Benchmarking
      11.4.4 Strategic Initiatives
      11.5 Zoetis
      11.5.1 Company Overview
      11.5.2 Financial Performance
      11.5.3 Product Benchmarking
      11.5.4 Strategic Initiatives
      11.6 Virbac
      11.6.1 Company Overview
      11.6.2 Financial Performance
      11.6.3 Product Benchmarking
      11.6.4 Strategic Initiatives
      11.7 Bimeda, Inc.
      11.7.1 Company Overview
      11.7.2 Product Benchmarking
      11.7.3 Financial Performance
      11.7.4 Strategic Initiatives
      11.8 Vivaldis
      11.8.1 Company Overview
      11.8.2 Product Benchmarking
      11.8.3 Financial Performance
      11.8.4 Strategic Initiatives
      11.9 Bioiberica S.A.U
      11.9.1 Company Overview
      11.9.2 Financial Performance
      11.9.3 Product Benchmarking
      11.9.4 Strategic Initiatives
      11.10 Indian Immunologicals Ltd
      11.10.1 Company Overview
      11.10.2 Financial Performance
      11.10.3 Product Benchmarking
      11.10.4 Strategic Initiatives

      For more information about this report visit https://www.researchandmarkets.com/r/lgyspo

      Media Contact:

      Research and Markets
      Laura Wood, Senior Manager
      [email protected]

      For E.S.T Office Hours Call +1-917-300-0470
      For U.S./CAN Toll Free Call +1-800-526-8630
      For GMT Office Hours Call +353-1-416-8900

      U.S. Fax: 646-607-1904
      Fax (outside U.S.): +353-1-481-1716

      SOURCE Research and Markets

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.